Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination — Stella

Recruiting

Back to Yellow Fever trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Oregon Health & Science University, Portland, Oregon

Key details

Phase

Early testing / Safety & dosing

Sponsor

Oregon Health and Science University

Enrollment target

~35 participants

Started

August 2023

Primary completion

November 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 49 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov